PPARGC1A and amyotrophic lateral sclerosis: However, indirect evidence came from the study of Bayer et al., demonstrating that in genetically modified SOD1 mice, the only ALS mouse model currently used, there was an increase of the canonical peripherical PGC-1α system and a reduction in CNS of the specific PGC-1α isoforms [95].